Model for End-Stage Liver Disease (MELD) exception for bacterial cholangitis

Liver Transplantation

Volumn 12, Issue 12 SUPPL. 3, 2006, Pages

  Gores, Gregory J ^a   Gish, Robert G ^b   Shrestha, Roshan ^c   Wiesner, Russell H ^a  

^a Mayo Clinic   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c Piedmont Liver Transplantation Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILIARY TRACT DISEASE; CHOLESTASIS; DISEASE ASSOCIATION; ENTERITIS; GRAFT FAILURE; GRAFT SURVIVAL; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; HYPERBILIRUBINEMIA; LIVER ABSCESS; LIVER DISEASE; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MORBIDITY; OSTEOMYELITIS; PATIENT SELECTION; PORTAL HYPERTENSION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; SEPTICEMIA; SURGICAL RISK; ULCERATIVE COLITIS;

BACTEREMIA; CHOLANGITIS, SCLEROSING; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; RECURRENCE; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT;

EID: 33845492624     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20966     Document Type: Article

References (9)

1. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989;10:430-436.
2. Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999;30:1121-1127.
3. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79;200-206.
4. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22:451-457.
5. Brandsaeter B, Friman S, Broome U, Isoniemi H, Olausson M, Backman L, et al. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand J Gastroenterol 2003;39:1176-1183.
6. Brandsaeter B, Broome U, Isoiemi H, Friman S, Hansen B, Schrumpf E, et al. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list. Liver Transpl 2003;9:961-969.
7. Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman I, Hansen B, et al. Liver transplantation for primary sclerosing cholangitis: predictors and consequences of hepatobiliary malignancy. J Hepatol 2004;40:815-822.
8. Khettry U, Keaveny A, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, et al. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study. Hum Pathol 2003;34:1127-1136.
9. Graziadei IW, Wiesner RH, Batts KP, Marotta PJ, LaRusso NF, Porayko MK, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999;29:1050-1056.